marches450 millionIpsen acquires Kartos Therapeutics for $450 million✓ Confirmed · 2 sources

Ipsen acquires Kartos Therapeutics for $450 million

French pharmaceutical group Ipsen finalizes the acquisition of US biotech Kartos Therapeutics.

Published 20sem2 sources✓ ConfirmedMajorupdated 14sem
Lire en français
≈ 16s

The fact

The deal, announced on June 28, 2026, strengthens its hematology oncology portfolio.

Kartos retains its Massachusetts headquarters and becomes a wholly-owned subsidiary.

2 sources — click a link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
États-Unis · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 2 media sources · identified on June 29, 2026
← Back to home
Discover

Read more

All marches →